Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.
about
CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.Metabolic syndrome as a risk factor for neurological disorders.Biomarker discovery in serum from patients with carotid atherosclerosisFibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study.Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.Diabetes-related microvascular and macrovascular diseases in the physical therapy settingAssociation of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients.Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.CD36 as a therapeutic target for endothelial dysfunction in stroke.Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.Antioxidant status in patients with acute myocardial infarction.Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran.The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans.Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.The extracellular chaperone haptoglobin prevents serum fatty acid-promoted amyloid fibril formation of β2-microglobulin, resistance to lysosomal degradation, and cytotoxicityAcute-phase proteins and incidence of diabetes: a population-based cohort study.Metabolism and secretory function of white adipose tissue: effect of dietary fat.Impact of Diabetes on Stroke Risk and Outcomes: Two Nationwide Retrospective Cohort Studies.Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate.Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?Investigation of the inflammatory biomarkers of metabolic syndrome in adolescents.Personalized protein corona on nanoparticles and its clinical implications.Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappaB activation and expressionInflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.Red blood cell distribution width is associated with incidence of atrial fibrillation.Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old.Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.Oral Magnesium Treatment Reduces Anemia and Levels of Inflammatory Markers in Experimental Diabetes.Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women.IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.
P2860
Q33697097-F3DDA3CD-384D-42A3-B2A4-B53CC8441E5EQ34224030-E217FD48-1541-47F3-A109-F34B486229B8Q34261476-F790CCE5-557B-4F1B-B4AB-D853F3ACA756Q34333952-84ECB87A-4276-4AF9-974B-F319C37E41BBQ34629523-19F76FA3-A235-46BE-A1B3-52D561926DABQ34767602-84030B13-134C-43E0-92B1-72BECF02E1E9Q34830905-224BD1DB-5180-419E-A4E4-1B18243CCF68Q34879819-7898D01B-8F8D-42AA-BB64-A3E06B4CFA4AQ35554200-BBBE61E5-4984-4788-952D-2C8DB063AFC8Q36139754-561A69A0-FFF0-4A0B-885F-2F46FAB52461Q36252726-D24CF56C-7175-4049-B68A-270E0DAA7819Q36266057-56DF4724-C4BC-4492-B88B-D66BF236DF01Q36546427-31856B0F-D1DD-4762-B555-4ECF893F7B43Q36666302-B0E2D36E-40B9-4C68-9312-7CEC4738C400Q37072778-DBEBDAFF-E29C-4C74-B6AD-17B414BDF5AFQ37289205-DDD4B92A-202A-48A1-AA5B-642342EC2941Q37421253-3B3B9DF4-9FDB-45AB-A317-9591DD0B0F5FQ37590183-3107E93E-CD3C-4558-BF99-117B159CF3D6Q37624185-3A515140-7B5C-4B89-BF66-4E80CB9C17E3Q37728670-2402E17A-FB27-4C50-A2FE-B21C70C423B8Q38673768-2FEEB052-799D-4852-8EDA-F43AB9EBFD17Q38809946-94908965-A7CB-4BBF-9B6B-C2CAD81C462FQ39108612-1922C5AF-7BD3-44ED-AC66-2BCE83191728Q41809945-2F03B039-8B61-4EC3-80DC-BC8C7A3BABF1Q43543562-CAFABD49-CE2B-4B88-9E29-28B5FB4C22C0Q45017560-3109DEC3-0291-4BE8-AF39-BCF6018CCE4FQ46080439-F901EDAC-8447-4FE9-BA08-288262FBF23DQ46892322-FF85914A-DFF8-40EF-8949-216705A0FA2EQ47131389-C698E937-E8EB-4A9B-9751-82259F6CF1EEQ47184283-49D2F301-9294-48F4-B3AB-96AD6051C6FCQ50232896-37F48BF8-B399-46A4-BA11-769FD93EAA24Q51468576-5EA9797B-B6E5-4C4F-A2E4-6AD0250C2B0FQ52582325-0770F1DD-8BA5-4F08-AA0A-5C8DA739EC42
P2860
Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inflammation-sensitive plasma ...... oke: a population-based study.
@en
Inflammation-sensitive plasma ...... oke: a population-based study.
@nl
type
label
Inflammation-sensitive plasma ...... oke: a population-based study.
@en
Inflammation-sensitive plasma ...... oke: a population-based study.
@nl
prefLabel
Inflammation-sensitive plasma ...... oke: a population-based study.
@en
Inflammation-sensitive plasma ...... oke: a population-based study.
@nl
P2093
P1433
P1476
Inflammation-sensitive plasma ...... oke: a population-based study.
@en
P2093
Bo Hedblad
Folke Lindgärde
Karl-Fredrik Eriksson
Lars Janzon
Lars Stavenow
Peter Lind
P304
P356
10.2337/DIABETES.52.2.442
P407
P577
2003-02-01T00:00:00Z